ALEXANDRIA, Va., July 23 -- United States Patent no. 12,364,777, issued on July 22, was assigned to MEDICOVESTOR INC. (Wilmington, Del.).

"Homodimeric antibodies for use in treating cancers and methods of use" was invented by Seah Lim (Wilmington, Del.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to homodimeric antibodies for use in treating cancer generally and to both homodimeric antibodies that bind human sperm protein 17 (Sp17) and homodimeric antibody immunoconjugates specifically. Such homodimeric antibodies display improved properties relative to monomeric antibodies, for example, because they can crosslink cells, improve cellular uptake, and/or carry greater payloads."

The ...